Clinical genetics of congenital hypothyroidism

Paediatric Thyroidology

Volumn , Issue , 2012, Pages 60-78

  Szinnai, Gabor ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84910680242     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000363156     Document Type: Chapter

References (97)

1. Polak M, Szinnai G: Thyroid disorders; in Rimoin DL, Pyeritz RE, Korf B (eds): Emery and Rimoin's Principles and Practice of Medical Genetics, ed 6. Philadelphia, Academic Press, 2013, chapt 84, pp 1-24.
2. Rastogi MN, LaFrancchi SH: Congenital hypothy- roidism. Orphanet J Rare Dis 2010;5:17.
3. Van Vliet G, Deladoëy J: Hypothyroidism in infants and children: congenital hypothyroidism; in Braver- man LE, Cooper D (eds): Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, ed 10. Philadelphia, Lippincott, Williams & Wilkins, 2012, pp 790-802
4. Polak M, Sura-Trueba S, Chauty A, Szinnai G, Carré A, Castanet M: Molecular mechanisms of thyroid dysgenesis. Horm Res 2004;62(suppl 3):14-21.
5. De Felice M, Di Lauro R: Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004;25:722-746.
6. Nilsson M, Fagman H: Mechanisms of thyroid de- velopment and dysgenesis: an analysis based on de- velopmental stages and concurrent embryonic anat- omy. Curr Top Dev Biol 2013;106:123-170.
7. Szinnai G: Genetics of normal and abnormal thyroid development in humans. Best Pract Res Clin Endo- crinol Metab 2014;28:133-150.
8. Czernichow P, Schlumberger M, Pomarede R, Fragu P: Plasma thyroglobulin measurements help deter- mine the type of thyroid defect in congenital hypo- thyroidism. J Clin Endocrinol Metab 1983;56:242- 245
9. Gagné N, Parma J, Deal C, Vassart G, Van Vliet G: Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin re- ceptor gene: are athyreosis and ectopic thyroid dis- tinct entities? J Clin Endocrinol Metab 1998;83: 1771-1775.
10. Léger J, Marinovic D, Garel C, Bonaïti-Pellié C, Po- lak M, Czernichow P: Thyroid developmental anom- alies in first degree relatives of children with con- genital hypothyroidism. J Clin Endocrinol Metab 2002;87:575-580.
11. Stoppa-Vaucher S, Lapointe A, Turpin S, Rydlewski C, Vassart G, Deladoëy J: Ectopic thyroid gland caus- ing dysphonia: imaging and molecular studies. J Clin Endocrinol Metab 2010;95:4509-4510.
12. Wildi-Runge S, Stoppa-Vaucher S, Lambert R, Tur- pin S, Van Vliet G, Deladoëy J: A high prevalence of dual thyroid ectopy in congenital hypothyroidism: evidence for insufficient signaling gradients during embryonic thyroid migration or for the polyclonal nature of the thyroid gland? J Clin Endocrinol Metab 2012;97:E978-E981
13. Trueba SS, Augé J, Mattei G, Etchevers H, Marti- novic J, Czernichow P, Vekemans M, Polak M, Attié- Bitach T: PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dys- genesis-associated malformations. J Clin Endocrinol Metab 2005;90:445-462.
14. Szinnai G, Lacroix L, Carré A, Guimiot F, Talbot M, Martinovic J, Delezoide AL, Vekemans M, Michiels S, Caillou B, Schlumberger M, Bidart JM, Polak M: Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetus. J Clin Endocrinol Metab 2007;92: 70-76.
15. Devos H, Rodd C, Gagne N, Laframboise R, Van Vliet G: A search for the possible molecular mecha- nisms of thyroid dysgenesis: sex ratios and associat- ed malformations. J Clin Endocrinol Metab 1999;84: 2502-2506.
16. Perry R, Heinrichs C, Bourdoux P, Khoury K, Szöts F, Dussault JH, Vassart G, van Vliet G: Discordance of monozygotic twins for thyroid dysgenesis: impli- cations for screening and for molecular pathophysi- ology. J Clin Endocrinol Metab 2002;87:4027-4077.
17. Castanet M, Polak M, Bonaïti-Pellié C, Lyonnet S, Czernichow P, Léger J: Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involve- ment of genetic factors. J Clin Endocrinol Metab 2001;86:2009-2014.
18. Castanet M, Marinovic D, Polak M, Léger J: Epide- miology of thyroid dysgenesis: the familial compo- nent. Horm Res Paediatr 2010;73:231-237.
19. Plachov D, Chouwhury K, Walther C, Simon D, Guenet JL, Gruss P: Pax8, a murine paired box gene expressed in the developing excretory system and the thyroid gland. Development 1990;110:643-651.
20. Mansouri A, Chouwhury K, Gruss P: Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 1998;19:87-90.
21. Pasca di Magliano M, Di Lauro R, Zannini MS: Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci USA 2000;97:13144-13149.
22. Carre A, Szinnai G, Castanet M, Sura-Trueba S, Tron E, Broutin-L'Hermite I, Barat P, Goizet C, Lacombe D, Moutard ML, Raybaud C, Raynaud-Ravni C, Ro- mana S, Ythier H, Léger J, Polak M: Five new TTF1/ NKX2-1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet 2009;18:2266-2276.
23. Antonica F, Figini Kasprzyk D, Opitz R, Iacovino M, Liao XH, Dumitrescu AM, Refetoff S, Peremans K, Manto M, Kyba M, Costagliola S: Generation of functional thyroid from embryonic stem cells. Na- ture 2012;491:66-71.
24. Macchia PE, Lapi P, Krude H, Pirro MT, Missero C, Chiovato L, Souabni A, Baserga M, Tassi V, Pinchera A, Fenzi G, Gruters A, Busslinger M, Di Lauro R: PAX8 mutations associated with congenital hypo- thyroidism caused by thyroid dysgenesis. Nat Genet 1998;19:83-86.
25. Meeus L, Gilbert B, Rydlewski C, Parma J, Roussie AL, Abramowicz M, Vilain C, Christophe D, Costa- gliola S, Vassart G: Characterization of a novel loss of function mutation of PAX8 in a familial case of congenital hypothyroidism with in-place, normal- sized thyroid. J Clin Endocrinol Metab 2004;89: 4285-4291.
26. Ramos HE, Carre A, Szinnai G, Tron E, Cerqueira TLO, Leger J, Cabrol S, Puel O, de Roux N, Polak M, Chevrier L, Castanet M: PAX8 mutations in congenital hypothyroidism: new evidence for phe- notypic variability from normal to ectopic thyroid gland. https://endo.confex.com/endo/2013endo/ webprogram/Paper5804.html.
27. Lazzaro D, Price M, De Felice M, Di Lauro R: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113: 1093-1104.
28. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ: The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10: 60-69.
29. Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S, Kimura S: Thyroid-specific enhancer-bind- ing protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differen- tiated thyroid. Mol Endocrinol 2006;20:1796-1809.
30. Guillot L, Carre A, Szinnai G, Castanet M, Tron E, Jaubert F, Broutin I, Counil F, Feldmann D, Clement A, Polak M, Epaud R: NKX2-1 mutations leading to surfactant protein promoter dysregulation cause in- terstitial lung disease in 'brain-lung-thyroid syn- drome'. Hum Mutat 2010;31:E1146.
31. Devriendt K, Vanhole C, Matthijs G, de Zegher F: Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respi- ratory failure. N Engl J Med 1998;338:1317-1318.
32. Krude H, Schutz B, Bibermann H, von Moers A, Sch- nabel D, Neitzel H, Tonnies H, Weise D, Lafferty A, Schwarz S, De Felice M, von Deimling A, van Lande- ghem F, Di Lauro R, Grueters A: Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109:475-480.
33. Pohlenz J, Dimitrescu A, Zundel D, Martine U, Sch- onberger W, Koo E, Weiss RE, Cohen RN, Kimura S, Refetoff S: Partial deficiency of thyroid transcription factor 1 produces predominantly neurological de- fects in humans and mice. J Clin Invest 2002;109: 469-473.
34. Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, Motte J, Rodriguez D, Louha M, Caubel I, Kemlin I, Lion-François L, Goizet C, Guillot L, Moutard ML, Epaud R, Héron B, Charles P, Tallot M, Camuzat A, Durr A, Polak M, Devos D, Sanlaville D, Vuillaume I, Billette de Villemeur T, Vidailhet M, Doummar D: Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/ NKX2-1 gene. J Neurol Neurosurg Psychiatry 2012; 83:956-962
35. Teissier R, Guillot L, Carré A, Morandini M, Stuck- ens C, Ythier H, Munnich A, Szinnai G, de Blic J, Clement A, Leger J, Castanet M, Epaud R, Polak M: Multiplex ligation dependent probe amplification improves the detection rate of NKX2-1 mutations in patients affected by brain-lung-thyroid syndrome. Horm Res Paediatr 2012;77:146-151.
36. Zannini M, Avantaggiato V, Biffali E, Arnone M, Sato K, Pischetola M, Taylor BA, Phillips SJ, Simeone A, Di Lauro R: TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the on- set of differentiation. EMBO J 1997;16:3185-3197.
37. De Felice M, Ovitt C, Biffali E, Arnone M, Sato K, Pischetola M, Taylor BA, Phillips SJ, Simeone A, Di Lauro R: A mouse model for hereditary thyroid dys- genesis and cleft palate. Nat Genet 1998;19:395-398.
38. Bamforth JS, Hughes IA, Lazarus JH, Weaver CM, Harper PS: Congenital hypothyroidism, spiky hair, and cleft palate. J Med Genet 1989;26:49-51.
39. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John RLJ, Ludgate M, Chatterjee VK: Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 1998;1:399-401.
40. Carré A, Hamza RT, Kariyawasam D, Guillot L, Teis- sier R, Tron E, Castanet M, Dupuy C, El Kholy M, Polak M: A novel FOXE1 mutation (R73S) in Bam- forth-Lazarus syndrome causing increased thyroidal gene expression. Thyroid 2014;24:649-654.
41. Moreno LM, Mansilla MA, Bullard SA, Cooper ME, Busch TD, Machida J, Johnson MK, Brauer D, Krahn K, Daack-Hirsch S, L'heureux J, Valencia-Ramirez C, Rivera D, López AM, Moreno MA, Hing A, Lam- mer EJ, Jones M, Christensen K, Lie RT, Jugessur A, Wilcox AJ, Chines P, Pugh E, Doheny K, Arcos-Bur- gos M, Marazita ML, Murray JC, Lidral AC: FOXE1 association with both isolated cleft lip with or with- out cleft palate, and isolated cleft palate. Hum Mol Genet 2009;18:4879-4896.
42. Reamon-Buettner SM, Borlak J: NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD). Hum Mutat 2010;31:1185-1194.
43. Olivieri A, Stazi MA, Mastoiacovo P, Fazzini C, Medda E, Spagnolo A, De Angelis S, Grandolo ME, Taruscio D, Cordeddu V, Scorcini M; Study Group for Congenital Hypothyroidism: A population based study on the frequency of additional congenital mal- formations in infants with congenital hypothyroid- ism: data from the Italian Registry for Congenital Hypothyroidism (1991-1998). J Clin Endocrinol Metab 2002;87:557-562.
44. Dentice M, Cordeddu V, Rosica A, Ferrare M, San- tarpia L, Salvatore D, Chivato L, Perri A, Moschini L, Fazzini C, Olivieri A, Costa P, Stoppioni V, Baserga M, De Felice M, Sorcini M, Fenzi G, Di Lauro R, Tar- taglia M, Maccia PE: Missense mutation in the tran- scription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endo- crinol Metab 2006;91:1428-1433.
45. Mulder BJ, Postma AV. The am- biguous role of NKX2-5 mutations in thyroid dys- genesis. PLoS One 2012;7:e52685.
46. Kleinau G, Neumann S, Grüters A, Krude H, Bieber- mann H: Novel insights on thyroid-stimulating hor- mone receptor signal transduction. Endocr Rev 2013;34:691-724.
47. Sunthornthepvarakul T, Gootschalk ME, Hayashi Y, Refetoff S: Resistance to thyrotropin caused by mu- tations in the thyrotropin-receptor gene. N Engl J Med 1995;332:155-160
48. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R: Role of the thyroid-stimulating hormone receptor signalling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 2002;99: 15462-15467.
49. Narumi S, Muroya K, Abe Y, Yasui M, Asakura Y, Adachi M, Hasegawa T: Nonclassical TSH mutations as a cause of congenital hypothyroidism in Japan: population based genetic epidemiology study. J Clin Endocrinol Metab 2009;94:1317-1323.
50. Alberti L, Proverbio MC, Costagliola S, Romoli R, Boldrighini B, Vigone MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L: Germline mutations of TSH receptor gene as cause of nonautoimmune sub- clinical hypothyroidism. J Clin Endocrinol Metab 2002;87:2549-2555.
51. Persani L, Calebiro D, Cordella D, Weber G, Gelmi- ni G, Libri D, de Filippis T, Bonomi M: Genetics and phenomics of hypothyroidism due to TSH resis- tance. Mol Cell Endocrinol 2010;322:72-82.
52. Nicoletti A, Bal M, De Marco G, Baldazzi L, Agretti P, Menabò S, Ballarini E, Cicognani A, Tonacchera M, Cassio A: Thyrotropin-stimulating hormone re- ceptor gene analysis in pediatric patients with non- autoimmune subclinical hypothyroidism. J Clin En- docrinol Metab 2009;94:4187-4194.
53. Xu PX, Zheng W, Leclef C, Maire P, Maas RL, Peters H, Xu X: Eay1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. De- velopment 2002;129:3033-3044.
54. Martinez-Barbera JP, Clements M, Thomas P, Ro- driguez T, Meloy D, Kioussis D, Beddington RS: The homeobox gene Hhex is required in definitive endo- dermal tissues for normal forebrain, liver and thy- roid formation. Development 2000;127:2433-2445.
55. Manley NR, Capecchi MR: The role of Hoxa-3 in mouse thymus and thyroid development. Develop- ment 1995;121:1989-2993.
56. Manley NR, Capecchi MR: Hox group 3 paralogs regulate the development and migration of the thy- mus, the thyroid, and parathyroid glands. Dev Biol 1998;195:1-15.
57. Westerlund J, Andersson L, Carlsson T, Zoppoli P, Fagman H, Nilsson M: Expression of Islet1 in thy- roid development related to budding, migration, and fusion of primordial. Dev Dyn 2008;237:3820-3829.
58. Fagman H, Grande M, Gritli-Linde A, Nilsson M: Genetic deletion of sonic hedgehog causes hemia- genesis and ectopic development of the thyroid in the mouse. Am J Pathol 2004;164:1865-1872.
59. Carré A, Rachdi L, Tron E, Richard B, Castanet M, Schlumberger M, Bidart JM, Szinnai G, Polak M: Hes1 is required for appropriate morphogenesis and differentiation during mouse thyroid gland develop- ment. PLoS One 2011;6:e16752
60. Narumi S, Muroya K, Asakura Y, Adachi M, Hasega- wa T: Transcription factor mutations and congenital hypothyroidism: systematic genetic screening of a population based cohort of Japanese patients. J Clin Endocrinol Metab 2010;95:1981-1985.
61. Narumi S, Muroya K, Asakura Y, Aachi M, Hasega- wa T: Molecular basis of thyroid dyshormonogene- sis: genetic screening in population-based Japanese patients. J Clin Endocrinol Metab 2011;96:E1838- E1842.
62. Carré A, Castanet M, Sura-Trueba S, Szinnai G, Van Vliet G, Trochet D, Amiel J, Léger J, Czernichow P, Scotet V, Polak M: Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum Genet 2007;122:467.
63. Conrad DF, Bird C, Blackburne B, Lindsay S, Ma- manova L, Lee C, Turner DJ, Hurles ME: Mutation spectrum revealed by breakpoint sequencing of hu- man germline CNVs. Nat Genet 2010;42:385-391.
64. Thorwarth A, Mueller I, Biebermann H, Ropers HH, Grueters A, Krude H, Ullmann R: Screening chro- mosomal aberrations by array comparative genomic hybridization in 80 patients with congenital hypo- thyroidism and thyroid dysgenesis. J Clin Endocri- nol Metab 2010;95:3446-3452
65. Vassart G, Dumont JE: Thyroid dysgenesis multi- genic or epigenetic...or both? Endocrinology 2005; 146:5035-5037.
66. Abu-Khudir R, Paquette J, Lefort A, Libert F, Cha- noine JP, Vassart G, Deladoëy J: Transcriptome, methylome and genetic variations analysis of ectopic thyroid glands. PLoS One 2010;5:e13420.
67. Knobel M, Medeires-Neto G: An outline of inherited disorders of the thyroid hormone generating system. Thyroid 2003;13:771-801.
68. Cavarzere P, Castanet M, Polak M, Raux-Demay MC, Cabrol S, Carel JC, Léger J, Czernichow P: Clin- ical description of infants with congenital hypothy- roidism and iodide organification defects. Horm Res 2008;70:240-248.
69. Clerc J: Imaging the thyroid in children. Best Pract Res Clin Endocrinol Metab 2014;28:203-220.
70. Portulano C, Paroder-Belenitsky M, Carrasco N: The Na+/I-symporter (NIS): mechanism and medi- cal impact. Endocr Rev 2014;35:106-149.
71. Stanbury JB, Chapman EM: Congenital hypothy- roidism with goitre: absence of an iodide-concen- trating mechanism. Lancet 1960;i:1162.
72. Fujiwara H, Tatsumi K, Miki K, Harada T, Miyai K, Taki S, Amino N: Congenital hypothyroidism caused by a mutation in the Na+/I- symporter. Nat Genet 1997;16:124-125.
73. Szinnai G, Kosugi S, Derrien C, Lucidarme N, David V, Czernichow P, Polak M: Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide sym- porter gene and review of genotype-phenotype cor- relations in ITD. J Clin Endocrinol Metab 2006;91: 1199-1204.
74. Pesce L, Bizhanova A, Caraballo JC, Westphal W, Butti ML, Comellas A, Kopp P: TSH regulates pen- drin membrane abundance and enhances iodide ef- flux in thyroid cells. Endocrinology 2012;153:512- 521.
75. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Hey- man M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate trans- porter gene (PDS). Nat Genet 1997;17:411-422.
76. Bizhanova A, Kopp P: Genetics and phenomics of Pendred syndrome. Mol Cell Endocrinol 2010;322: 83-90.
77. Ladsous M, Vlaeminck-Guillem V, Dumur V, Vin- cent C, Dubrulle F, Dhaenens CM, Wémeau JL: Analysis of the thyroid phenotype in 42 patients with Pendred syndrome and nonsyndromic enlargement of the vestibular aqueduct. Thyroid 2014;24:639- 648.
78. Kühnen P, Turan S, Fröhler S, Güran T, Abali S, Biebermann H, Bereket A, Grüters A, Chen W, Krude H: Identification of pendrin (SLC26A4) mu- tations in patients with congenital hypothyroidism and 'apparent' thyroid dysgenesis. J Clin Endocrinol Metab 2014;99:E169-E176.
79. Ris-Stalpers C, Bikker H: Genetics and phenomics of hypothyroidism and goiter due to TPO mutations. Mol Cell Endocrinol 2010;322:38-43.
80. Abramowicz MJ, Targovnik HM, Varela V, Cochaux P, Krawiec L, Pisarev MA, Propato FV, Juvenal G, Chester HA, Vassart G: Identification of a mutation in the coding sequence of the human thyroid per- oxidase gene causing congenital goiter. J Clin Invest 1992;90:1200-1204.
81. Bakker B, Bikker H, Vulsma T, de Randamie JSE, Wiedijk BM, De Vijlder JJM: Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endori- nol Metab 2000;85:3708-3712.
82. Nascimento AC, Guedes DR, Santos CS, Knobel M, Rubio IG, Medeiros-Neto G: Thyroperoxidase gene mutations in congenital goitrous hypothyroidism with total and partial iodide organification defect. Thyroid 2003;13:1145-1151.
83. Deladoëy J, Pfarr N, Vuissoz JM, Parma J, Vassart G, Biesterfeld S, Pohlenz J, Van Vliet G: Pseudodomi- nant inheritance of goitrous congenital hypothy- roidism caused by TPO mutations: molecular and in silico studies. J Clin Endocrinol Metab 2008;93:627- 633.
84. Moreno JC, Bikker H, Kempers MJE, van Trotsen- burg AS, Baas F, de Vijlder JJM, Vulsma T, Ris-Stalp- ers C: Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002;347:95-102.
85. Maruo Y, Takahashi H, Soeda I, Nishikura N, Matsui K, Ota Y, Mimura Y, Mori A, Sato H, Takeuchi Y: Transient congenital hypothyroidism caused by bi- allelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program. J Clin Endocrinol Metab 2008;93:4261- 4267.
86. Hoste C, Rigutto S, Van Vliet G, Miot F, De Deken X: Compound heterozygosity for a novel hemizy- gous missense mutation and a partial deletion affect- ing the catalytic core of the H2O2-generating enzyme DUOX2 associated with transient congenital hypo- thyroidism. Hum Mutat 2010;31:E1304-E1319.
87. Muzza M, Rabbiosi S, Vigone M, Zamproni I, Cire- llo V, Maffini M, Maruca K, Schoenmakers N, Bec- caria L, Gallo F, Park SM, Beck-Peccoz P, Persani L, Weber G, Fugazzola L: The clinical and molecular characterization of patients with dyshormonogeneic congenital hypothyroidism reveals specific diagnos- tic clues for DUOX2 defects. J Clin Endocrinol Metab 2014;99:E544-E553.
88. Zamproni I, Grasberger H, Cortinovis F, Vigone MC, Chiumello G, Mora S, Onigata K, Fugazzola L, Refetoff S, Persani L, Weber G: Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 2008;93:605-610.
89. Targovnik HM, Esperante SA, Rivolta CM: Genetics and phenomics of hypothyroidism and goiter due to thyroglobulin mutations. Mol Cell Endocrinol 2010; 322:44-55.
90. Ieiri T, Cochaux P, Targovnik HM, Suzuki M, Shi- moda S, Perret J, Vassart G: A 3'-splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 1991;88: 1901-1905.
91. Medeiros-Neto G, Kim PS, Yoo SE, Vono J, Targov- nik H, Camargo R, Hossain SA, Arvan P: Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 1996;98:2838-2844.
92. Citterio CE, Rossetti LC, Souchon PF, Morales C, Thouvard-Viprey M, Salmon-Musial AS, Mauran PL, Doco-Fenzy M, González-Sarmiento R, Rivolta CM, De Brasi CD, Targovnik HM: Novel mutational mechanism in the thyroglobulin gene: imperfect DNA inversion as a cause for hereditary hypothy- roidism. Mol Cell Endocrinol 2013;381:220-229.
93. Iglesias A, García-Nimo L, Cocho de Juan JA, More- no JC: Towards the pre-clinical diagnosis of hypo- thyroidism caused by iodotyrosine deiodinase (DEHAL1) defects. Best Pract Res Clin Endocrinol Metab 2014;28:151-159.
94. Moreno JC, Klootwijk W, van Toor H, Pinto G, D'Allessandro M, Leger A, Goudie D, Polak M, Grüters A, Visser TJ: Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med 2008;358:1856-1859.
95. Afink G, Kulik W, Overmars H, de Randamie J, Veenboer T, van Cruchten A, Craen M, Ris-Stalpers C: Molecular characterization of iodotyrosine deha- logenase deficiency in patients with hypothyroidism. J Clin Endocrinol Metab 2008;93:4894.
96. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, Polak M, Butler G; ESPE- PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group: European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 2014;99:363-384.
97. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, Polak M, Butler G: European Society for Paediatric Endocrinology Consensus Guidelines on screening, diagnosis, and manage- ment of congenital hypothyroidism. Horm Res Paed 2014;81:80-103.